Biosynex SA acquired 57.33% interest in ProciseDx Inc. from Nestlé HealthCare Nutrition, Inc., other shareholders, employees, former employees and investors.
Biosynex SA (ENXTPA:ALBIO) completed the acquisition of 57.33% interest in ProciseDx Inc. from Nestlé HealthCare Nutrition, Inc., other shareholders, employees, former employees and investors on June 13, 2023. Wilson Sonsini Goodrich & Rosati, P.C. acted as legal advisor to ProciseDx Inc.